journal article·2013-12-26

Graphene Oxide Based Theranostic Platform forT1-Weighted Magnetic Resonance Imaging and Drug Delivery

Mengxin Zhang, Yuhua Cao, Yu Chong, Yufei Ma, Hailu Zhang, Zongwu Deng, Chunhong Hu, Zhijun Zhang

Publisher page

Abstract

Magnetic resonance imaging (MRI) is a powerful and widely used clinical technique in cancer diagnosis. MRI contrast agents (CAs) are often used to improve the quality of MRI-based diagnosis. In this work, we developed a positive T1 MRI CA based on graphene oxide (GO)-gadolinium (Gd) complexes. In our strategy, diethylenetriaminepentaacetic acid (DTPA) is chemically conjugated to GO, followed by Gd(III) complexation, to form a T1 MRI CA (GO-DTPA-Gd). We have demonstrated that the GO-DTPA-Gd system significantly improves MRI T1 relaxivity and leads to a better cellular MRI contrast effect than Magnevist, a commercially used CA. Next, an anticancer drug, doxorubicin (DOX), was loaded on the surface of GO sheets via physisorption. Thus-prepared GO-DTPA-Gd/DOX shows significant cytotoxicity to the cancer cells (HepG2). This work provides a novel strategy to build a GO-based theranostic nanoplatform with T1-weighted MRI, fluorescence imaging, and drug delivery functionalities.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Graphene research and applications · Carbon and Quantum Dots Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Suzhou Key Laboratory of Nanobiomedicine, Division of Nanobiomedicine, Suzhou Institute of Nano-tech and Nano-bionics, Chinese Academy of Sciences, 398 Ruoshui Road, Suzhou 215123, China

University of Chinese Academy of Sciences, 19 (A) Yuquan Road, Beijing 100049, China

Division of Nanobionics, Suzhou Institute of Nano-tech and Nano-bionics, Chinese Academy of Sciences, 398 Ruoshui Road, Suzhou 215123, China

Imaging Centre, The First Affiliated Hospital of Soochow University, Suzhou 215006, China

References (43)

Show source-provided references
1. Chaughule R. S. · Proc. Natl. Acad. Sci., India, Sect. A · 2012 · 82 · 25710.1007/s40010-012-0038-4 ↗
2. Zhou Z. X. · Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. · 2013 · 5 · 110.1002/wnan.1198 ↗
3. Caravan P. · Chem. Rev. · 1999 · 99 · 229310.1021/cr980440x ↗
4. Laurent S. · Chem. Rev. · 2008 · 108 · 206410.1021/cr068445e ↗
5. Letourneau M. · J. Phys. Chem. B · 2012 · 116 · 1322810.1021/jp3032918 ↗
6. Ma X. H. · J. Mater. Chem. B · 2013 · 1 · 341910.1039/c3tb20648c ↗
7. Cheng Y. Y. · Chem. Soc. Rev. · 2011 · 40 · 267310.1039/c0cs00097c ↗
8. Botta M. · Eur. J. Inorg. Chem. · 2012 · 194510.1002/ejic.201101305 ↗
9. Mikawa M. · Bioconjugate Chem. · 2001 · 12 · 51010.1021/bc000136m ↗
10. Bolskar R. D. · J. Am. Chem. Soc. · 2003 · 125 · 547110.1021/ja0340984 ↗
11. Zhen M. M. · ACS Appl. Mater. Interfaces · 2012 · 4 · 372410.1021/am300817z ↗
12. Sitharaman B. · Chem. Commun. · 2005 · 391510.1039/b504435a ↗
13. Hartman K. B. · Nano Lett. · 2008 · 8 · 41510.1021/nl0720408 ↗
14. Gianolio E. · Eur. J. Inorg. Chem. · 2012 · 2012 · 193410.1002/ejic.201101399 ↗
15. Geim A. K. · Nat. Mater. · 2007 · 6 · 18310.1038/nmat1849 ↗
16. Neto A. C. · Rev. Mod. Phys. · 2009 · 81 · 10910.1103/RevModPhys.81.109 ↗
17. Schwierz F. · Nat. Nanotechnol. · 2010 · 5 · 48710.1038/nnano.2010.89 ↗
18. Chen D. · Chem. Soc. Rev. · 2010 · 39 · 315710.1039/b923596e ↗
19. Sun Y. Q. · Energy Environ. Sci. · 2011 · 4 · 111310.1039/c0ee00683a ↗
20. Sun X. M. · Nano Res. · 2008 · 1 · 20310.1007/s12274-008-8021-8 ↗
21. Pan Y. Z. · Expert Opin. Drug Delivery · 2012 · 9 · 136510.1517/17425247.2012.729575 ↗
22. Shen H. · Theranostics · 2012 · 2 · 28310.7150/thno.3642 ↗
23. Feng L. Z. · Nanomedicine · 2011 · 6 · 31710.2217/nnm.10.158 ↗
24. Shen A. J. · J. Biomed. Mater. Res. A · 2012 · 100 · 249910.1002/jbm.a.34148 ↗
25. Liu Z. · J. Am. Chem. Soc. · 2008 · 130 · 1087610.1021/ja803688x ↗
26. Zhang L. M. · Small · 2011 · 7 · 46010.1002/smll.201001522 ↗
27. Singh S. K. · ACS Nano · 2011 · 5 · 498710.1021/nn201092p ↗
28. Yang K. · ACS Nano · 2010 · 5 · 51610.1021/nn1024303 ↗
29. Singh S. K. · ACS Nano · 2012 · 6 · 273110.1021/nn300172t ↗
30. Janib S. M. · Drug Delivery Rev. · 2010 · 62 · 105210.1016/j.addr.2010.08.004 ↗
31. Kelkar S. S. · Bioconjugate Chem. · 2011 · 22 · 187910.1021/bc200151q ↗
32. Choi K. Y. · Nanoscale · 2012 · 4 · 33010.1039/C1NR11277E ↗
33. Zhang L. M. · Small · 2010 · 6 · 53710.1002/smll.200901680 ↗
34. Chen Z. J. · J. Drug Targeting · 2011 · 19 · 65710.3109/1061186X.2010.531727 ↗
35. Liu Y. J. · Biomaterials · 2012 · 33 · 536310.1016/j.biomaterials.2012.03.084 ↗
36. Hong H. · Biomaterials · 2012 · 33 · 414710.1016/j.biomaterials.2012.02.031 ↗
37. Sherlock S. P. · ACS Nano · 2011 · 5 · 150510.1021/nn103415x ↗
38. Wu L. · Adv. Mater. · 2012 · 24 · 244710.1002/adma.201200412 ↗
39. Zhang L. M. · J. Mater. Chem. B · 2013 · 1 · 74910.1039/C2TB00096B ↗
40. Shen H. · ACS Appl. Mater. Interfaces · 2012 · 4 · 631710.1021/am3019367 ↗
41. Yang X. M. · ACS Appl. Mater. Interfaces · 2010 · 2 · 170710.1021/am100222m ↗
42. Huang J. · Nanoscale · 2013 · 5 · 1059110.1039/c3nr03264g ↗
43. Huang J. · Small · 2012 · 8 · 257710.1002/smll.201102743 ↗